Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|June 7, 2012
Immunomodulatory agents in myelofibrosisAli Tabarroki, Ramon V TiuTranslational Medicine @ Unisa|April 30, 2014
Molecular genetics of myelofibrosis and its associated disease phenotypesAli Tabarroki, Ramon V TiuSAGE Open Medical Case Reports|August 5, 2016
A case of mistaken identity: When lupus masquerades as primary myelofibrosisEdy Hasrouni, Heesun J Rogers, Ali Tabarroki, et al.Therapeutic Advances in Hematology|November 1, 2014
Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutationsJing Ai, Ramon V TiuThe Journal of Community and Supportive Oncology|April 2, 2015
Current and novel therapeutic approaches in myelodysplastic syndromesFayez Estephan, Ramon V TiuExpert Opinion on Biological Therapy|June 14, 2008
The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromesRamon V Tiu, Mikkael A SekeresCurrent Opinion in Hematology|January 1, 2014
Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromesRamon V Tiu, Mikkael A SekeresJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 11, 2013
Biological rationale and clinical use of interferon in the classical BCR-ABL-negative myeloproliferative neoplasmsBrady L Stein, Ramon V TiuClinical Lymphoma, Myeloma & Leukemia|May 16, 2015
Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic SyndromesJing Ai, Valeria Visconte, Ali Tabarroki, et al.British Journal of Haematology|July 1, 2009
Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignanciesJaroslaw P Maciejewski, Ramon V Tiu, Christine O'KeefePageof 8